In short

Anxiety disorders are characterised by persistent, excessive worry, physical tension, and autonomic arousal, producing symptoms ranging from persistent low-level unease to acute panic attacks, that are disproportionate to the actual threat and that significantly impair daily function. At CLCC, care for anxiety follows a five-step structured assessment: Assess, Identify, Reduce, Restore, Continue, addressing the systemic contributors alongside standard medical treatment, rather than symptom management alone.

About This Condition

Anxiety has physiological drivers that are correctable, and rarely assessed.

Anxiety disorders are characterised by persistent, excessive worry, physical tension, and autonomic arousal, producing symptoms ranging from persistent low-level unease to acute panic attacks, that are disproportionate to the actual threat and that significantly impair daily function. Standard management is psychological, CBT, mindfulness, SSRI medication. These are appropriate for many patients. But the physiological contributors to anxiety are frequently not assessed or addressed.

Blood sugar instability produces adrenaline release during glucose dips, directly triggering anxiety-like physical symptoms. Gut dysbiosis reduces GABA production, the primary inhibitory neurotransmitter that calms nervous system activity. Magnesium deficiency lowers the threshold for neuronal excitation and is associated with anxiety. B vitamin deficiencies impair neurotransmitter synthesis. Thyroid dysfunction, even subclinical, produces autonomic arousal that mimics anxiety. Caffeine and stimulant use amplify all of these. CLCC assesses these physiological contributors and addresses them, working alongside psychological support where it is in place, not as a replacement.

Symptoms

Common symptoms and presentations.

Persistent worry that is difficult to control
Restlessness or inability to settle, mind and body both activated
Physical tension, muscle tightness, particularly shoulders, jaw, and neck
Palpitations or racing heart
Shortness of breath or chest tightness without cardiac cause
Gut symptoms, nausea, loose stools, or bloating associated with anxiety states
Sleep difficulty, racing thoughts at sleep onset or waking with worry
Hypervigilance, constant scanning for threat
Fatigue from sustained nervous system activation
Panic attacks, acute episodes of intense physical anxiety symptoms
Contributing Factors

What drives and sustains this condition.

Gut dysbiosis and reduced GABA production
The gut produces and modulates GABA, the primary inhibitory neurotransmitter that calms nervous system activity. Gut dysbiosis reduces GABA availability, lowering the inhibitory tone that prevents anxiety escalation. Gut restoration helps reduce anxiety in patients with concurrent gut symptoms.
Blood sugar instability
Hypoglycaemic episodes trigger adrenaline release that produces anxiety symptoms, palpitations, tremor, sweating, and panic, that are physiologically identical to anxiety attacks. Blood sugar stabilisation through dietary correction eliminates these episodes.
Magnesium deficiency
Magnesium is required for NMDA receptor regulation and GABAergic neurotransmission. Deficiency increases neuronal excitability and lowers the threshold for anxiety activation. It is one of the most commonly identified nutritional contributors to anxiety.
HPA axis dysregulation
Sustained stress load dysregulates the HPA axis, producing abnormal cortisol patterns that maintain sympathetic nervous system activation, lower the threshold for fight-or-flight responses, and sustain the physiological state of anxiety independently of environmental stressors.
The CLCC Method: All Five Steps

Assessment first. Then all five steps, applied specifically.

01
Assess
Assess gut health, blood sugar, magnesium, thyroid, and cortisol pattern
Gut microbiome indicators and GABA-producing bacterial species. Fasting insulin and blood sugar pattern. Magnesium, B vitamins, vitamin D. Full thyroid panel. Cortisol pattern, morning and afternoon. Caffeine and stimulant intake reviewed. Anxiety severity scored at baseline.
02
Identify
Identify dominant physiological contributors, gut, metabolic, nutritional, or HPA
Gut-dominant anxiety responds primarily to microbiome restoration. Metabolic anxiety (blood sugar driven) responds to dietary correction. Nutritional deficiency anxiety responds to magnesium and B vitamin repletion. HPA-driven anxiety requires adrenal and cortisol-pattern correction.
03
Reduce
Targeted physiological correction alongside nervous system support
Gut restoration where gut-dominant. Blood sugar stabilisation through dietary structure. Magnesium glycinate at therapeutic doses. B vitamin complex. Thyroid support where indicated. HPA axis correction with adaptogenic support. Caffeine reduction structured where relevant.
04
Restore
Track anxiety severity, sleep quality, and physiological markers at monthly intervals
Validated anxiety scoring reviewed monthly. Sleep quality assessed. Blood sugar pattern and nutritional markers reviewed at 3 months. Gut health indicators tracked. Protocol refined based on measured response.
05
Continue
Sustain nervous system regulation through long-term physiological maintenance
Anxiety recurs when the physiological state that sustains it, gut dysbiosis, blood sugar instability, magnesium depletion, reaccumulates. The Continue phase monitors key physiological variables and provides structured support to maintain the nervous system regulation achieved.
FAQs

Common questions about care.

Does CLCC replace therapy or medication for anxiety?+
No. Psychological support, including CBT, mindfulness, and medication where appropriate, is appropriate for many anxiety presentations and CLCC care runs alongside it. CLCC addresses the physiological contributors that psychological support cannot: gut health, blood sugar regulation, nutritional deficiencies, and HPA dysregulation. The physiological and psychological dimensions of anxiety are both real and both require attention.
Can gut health really affect anxiety?+
Yes, directly. The gut produces approximately 95% of the body's serotonin and significant quantities of GABA. Gut dysbiosis reduces the production of these inhibitory neurotransmitters and increases gut-derived inflammatory compounds that activate the sympathetic nervous system. Gut restoration helps reduce anxiety in patients with concurrent gut symptoms, through a direct, physiological mechanism, not a placebo effect.